| Year |
Citation |
Score |
| 2020 |
Garg A, Hakeem H, Divita M, Grewal J, Cohen M, Lapa A. ST-elevation myocardial infarction in a young patient with anomalous right coronary artery and COVID-19 pneumonia. European Heart Journal. Case Reports. 4: 1-2. PMID 33117958 DOI: 10.1093/Ehjcr/Ytaa198 |
0.38 |
|
| 2020 |
Gencer B, Li XS, Gurmu Y, Bonaca MP, Morrow DA, Cohen M, Bhatt DL, Steg PG, Storey RF, Johanson P, Wang Z, Hazen SL, Sabatine MS. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial. Journal of the American Heart Association. e015331. PMID 32366163 DOI: 10.1161/Jaha.119.015331 |
0.346 |
|
| 2020 |
Garg A, Rout A, Sharma A, Sargsyan D, Tantry U, Gurbel P, Rao SV, Kostis JB, Cohen M. Safety and efficacy of antiplatelet regimens after percutaneous coronary intervention using drug eluting stents: A network meta-analysis of randomized controlled trials. Progress in Cardiovascular Diseases. PMID 32247786 DOI: 10.1016/J.Pcad.2020.03.018 |
0.318 |
|
| 2020 |
DiVita M, Visveswaran GK, Makam K, Naji P, Cohen M, Kapoor S, Saunders CR, Zucker MJ. Emergent TandemHeart-ECMO for acute severe mitral regurgitation with cardiogenic shock and hypoxaemia: a case series. European Heart Journal. Case Reports. 4: 1-6. PMID 32128490 DOI: 10.1093/Ehjcr/Ytz234 |
0.346 |
|
| 2020 |
Fan M, Kang JJ, Lee A, Fan D, Wang H, Kitpanit S, Fox P, Sine K, Mah D, McBride SM, Tsai CJ, Riaz N, Dunn LA, Sherman EJ, Michel L, ... ... Cohen MA, et al. Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies. Cancer. PMID 32097507 DOI: 10.1002/Cncr.32776 |
0.31 |
|
| 2020 |
Cohen M, Visveswaran G. Defining and managing patients with non-ST-elevation myocardial infarction: Sorting through type 1 vs other types. Clinical Cardiology. PMID 31923336 DOI: 10.1002/Clc.23308 |
0.307 |
|
| 2020 |
Ha ET, Cohen M, Fields PJ, Daele JV, Gaeta TJ. The Utility of Echocardiography for Non-ST-Segment Elevation Myocardial Infarction: A Retrospective Study: Journal of Diagnostic Medical Sonography. 36: 121-129. DOI: 10.1177/8756479319886572 |
0.344 |
|
| 2020 |
Okoh AK, Singh S, Obaidi N, Haik B, Chen C, Cohen M, Waxman S, Agarwal S, Russo M. CRT-600.10 Renin-Angiotensin-Aldosterone System Inhibitors Are Associated With Reno-Protective Effects in Aging Patients Undergoing Transcatheter Aortic Valve Replacement Jacc-Cardiovascular Interventions. 13. DOI: 10.1016/J.Jcin.2020.01.156 |
0.32 |
|
| 2020 |
Singh S, Okoh AK, Khakwani Z, Hakeem H, Pilani H, Grewal J, Visveswaran G, Michael D, Agarwal S, Waxman S, Cohen M. CRT-200.17 Impact of Race on Clinical Outcomes After Stent Revascularization for High-Grade Renal Artery Stenosis: A Single-Center Experience Jacc-Cardiovascular Interventions. 13. DOI: 10.1016/J.Jcin.2020.01.105 |
0.308 |
|
| 2020 |
Kitpanit S, Lee A, Fan D, Fan M, Wang H, Mohamed N, Spielsinger D, Gelblum D, Sherman E, Dunn L, Boyle JO, Wong RJ, Cohen M, Kang JJ, Tsai CJ, et al. Clinical Outcomes and Toxicities in Oropharyngeal Cancer (OPC) Patients Treated with Proton Therapy: A Single Institutional Experience International Journal of Radiation Oncology Biology Physics. 106: 1152-1153. DOI: 10.1016/J.Ijrobp.2019.11.231 |
0.302 |
|
| 2019 |
Pollack CV, Amin A, Wang T, Deitelzweig S, Cohen M, Slattery D, Fanikos J, DiLascia C, Tuder R, Kaatz S. Contemporary NSTEMI management: The role of the hospitalist. Hospital Practice (1995). PMID 31815570 DOI: 10.1080/21548331.2020.1701329 |
0.311 |
|
| 2019 |
Kerneis M, Yee MK, Mehran R, Nafee T, Bode C, Halperin JL, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Fox KAA, Gibson CM. Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial. Circulation. Cardiovascular Interventions. 12: e008160. PMID 31707805 DOI: 10.1161/Circinterventions.119.008160 |
0.309 |
|
| 2019 |
Garg A, Thawabi M, Rout A, Sossou C, Cohen M, Kostis JB. Recurrent Stroke Reduction with Patent Foramen Ovale Closure versus Medical Therapy Based on Patent Foramen Ovale Characteristics: A Meta-Analysis of Randomized Controlled Trials. Cardiology. 1-10. PMID 31574522 DOI: 10.1159/000500501 |
0.307 |
|
| 2019 |
Okoh AK, Sossou C, Kang N, Decker J, Dave D, Haik B, Chen C, Cohen M, Russo M. Left Ventricular Function Recovery After Transapical TAVR in Patients With Previous Coronary Artery Bypass Graft Surgery. Innovations (Philadelphia, Pa.). 1556984519864080. PMID 31354084 DOI: 10.1177/1556984519864080 |
0.347 |
|
| 2019 |
Husain Q, Joshi RR, Cracchiolo JR, Roman BR, Ganly I, Tabar V, Cohen MA. Surgical Management Patterns of Sinonasal Malignancy: A Population-Based Study. Journal of Neurological Surgery. Part B, Skull Base. 80: 371-379. PMID 31316883 DOI: 10.1055/S-0038-1675233 |
0.315 |
|
| 2019 |
Dellborg M, Bonaca MP, Storey RF, Steg PG, Im KA, Cohen M, Bhatt DL, Ophuis TO, Budaj A, Hamm C, Spinar J, Kiss RG, Lopez-Sendon J, Kamensky G, Van de Werf F, et al. Efficacy and Safety with Ticagrelor in Patients with Prior Myocardial Infarction in the Approved European label: Insights from PEGASUS-TIMI 54. European Heart Journal. Cardiovascular Pharmacotherapy. PMID 31218354 DOI: 10.1093/ehjcvp/pvz020 |
0.342 |
|
| 2019 |
Hawatmeh A, Thawabi M, Aggarwal R, Abirami C, Vavilin I, Wasty N, Visveswaran G, Cohen M. Implications of misclassification of type 2 myocardial infarction on clinical outcomes. Cardiovascular Revascularization Medicine : Including Molecular Interventions. PMID 31078438 DOI: 10.1016/J.Carrev.2019.04.009 |
0.33 |
|
| 2019 |
Garg A, Rout A, Tayal R, Sharma A, Agrawal S, Kostis JB, Cohen M, Sharma S, Wasty N. Drug-eluting Stents Versus Bare-metal Stents for Saphenous Vein Graft Interventions: A Systematic Review and Meta-analysis of Studies With Longer Follow-up. Current Problems in Cardiology. PMID 30792045 DOI: 10.1016/J.Cpcardiol.2018.12.002 |
0.355 |
|
| 2019 |
Kerneis M, Yee MK, Mehran R, Nafee T, Bode C, Halperin JL, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Fox KAA, Gibson CM. Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention. Circulation. Cardiovascular Interventions. 12: e007124. PMID 30704287 DOI: 10.1161/Circinterventions.118.007124 |
0.368 |
|
| 2019 |
Marquis-Gravel G, Thiele H, Jones WS, Smalling RW, Cohen M, Perera D, Pijls N, Fanaroff A, Brucker A, Chiswell K, Patel MR, Ohman EM. Size of Anterior Wall Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention in United States Versus Europe/Australia Versus India (from the CRISP-AMI Randomized Controlled Trial). The American Journal of Cardiology. PMID 30642606 DOI: 10.1016/J.Amjcard.2018.12.027 |
0.388 |
|
| 2019 |
George J, Cohen M, Whitney S, Fennern E, Divino C. Biliary Disease in Immunocompromised Patients: a Single-Center Retrospective Analysis. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. PMID 30635828 DOI: 10.1007/S11605-018-04077-W |
0.333 |
|
| 2019 |
Hawatmeh A, Thawabi M, Visveswaran G, Cohen M. Treatment And Outcomes Of Type 2 Myocardial Infarction Compared With Type 1 Myocardial Infarction Journal of the American College of Cardiology. 73: 161. DOI: 10.1016/S0735-1097(19)30769-7 |
0.337 |
|
| 2018 |
Bonaca MP, Wiviott SD, Morrow DA, Steg PG, Hamm C, Bhatt DL, Storey RF, Cohen M, Kuder J, Im K, Magnani G, Budaj A, Nicolau JC, Parkhomenko A, López-Sendón J, et al. Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54. Journal of the American Heart Association. 7: e009260. PMID 30571502 DOI: 10.1161/Jaha.118.009260 |
0.393 |
|
| 2018 |
Korjian S, Daaboul Y, Laliberté F, Zhao Q, Mehran R, Bode C, Halperin J, Verheugt FWA, Lip GYH, Cohen M, Peterson ED, Fox KAA, Gibson CM, Pinto DS. Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis). The American Journal of Cardiology. PMID 30502047 DOI: 10.1016/J.Amjcard.2018.10.033 |
0.307 |
|
| 2018 |
Korjian S, Braunwald E, Daaboul Y, Mi M, Bhatt DL, Verheugt FWA, Cohen M, Bode C, Burton P, Plotnikov AN, Gibson CM. Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial). The American Journal of Cardiology. PMID 30340765 DOI: 10.1016/J.Amjcard.2018.08.034 |
0.379 |
|
| 2018 |
Kerneis M, Gibson CM, Cohen M. Reply: In Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention, One Size Cannot Fit All. Jacc. Cardiovascular Interventions. 11: 1539-1540. PMID 30093062 DOI: 10.1016/J.Jcin.2018.04.028 |
0.334 |
|
| 2018 |
Garg A, Agrawal S, Cohen M. Early Angiography Use in Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States: Focus on Elderly Patients. Jacc. Cardiovascular Interventions. 11: 1418. PMID 30025736 DOI: 10.1016/J.Jcin.2018.03.036 |
0.349 |
|
| 2018 |
Chi G, Kerneis M, Kalayci A, Liu Y, Mehran R, Bode C, Halperin JL, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Peterson ED, Fox KAA, Gibson CM. Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial. American Heart Journal. 203: 17-24. PMID 30015064 DOI: 10.1016/J.Ahj.2018.06.003 |
0.31 |
|
| 2018 |
Chi G, Yee MK, Kalayci A, Kerneis M, AlKhalfan F, Mehran R, Bode C, Halperin JL, Verheugt FWA, Wildgoose P, van Eickels M, Lip GYH, Cohen M, Peterson ED, Fox KAA, et al. Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention. Journal of Thrombosis and Thrombolysis. PMID 29943350 DOI: 10.1007/S11239-018-1703-5 |
0.36 |
|
| 2018 |
Dillinger JG, Ducrocq G, Elbez Y, Cohen M, Bode C, Pollack C, Nicolau JC, Henry P, Kedev S, Wiviott SD, Sabatine MS, Mehta SR, Steg PG. Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial. Circulation. Cardiovascular Interventions. 11: e006084. PMID 29895599 DOI: 10.1161/Circinterventions.118.006084 |
0.4 |
|
| 2018 |
Kerneis M, Gibson CM, Chi G, Mehran R, AlKhalfan F, Talib U, Pahlavani S, Mir M, Bode C, Halperin JL, Nafee T, Peterson ED, Verheugt FWA, Wildgoose P, van Eickels M, ... ... Cohen M, et al. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial. Jacc. Cardiovascular Interventions. PMID 29550085 DOI: 10.1016/J.Jcin.2017.11.009 |
0.371 |
|
| 2018 |
Magnuson EA, Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Braunwald E, Sabatine MS, Cohen DJ. Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups. Journal of the American College of Cardiology. 71: 108. PMID 29301623 DOI: 10.1016/J.Jacc.2017.10.079 |
0.383 |
|
| 2018 |
Thawabi M, Cohen M, Ramcharitar R, Hawatmeh A, Shao J. Interdisciplinary Team Approach For Endovascular Management Of Patients With Critical Limb Ischemia Journal of the American College of Cardiology. 71. DOI: 10.1016/S0735-1097(18)32594-4 |
0.318 |
|
| 2018 |
Garg A, Rao SV, Rout A, Thawabi M, Wasty N, Cohen M. Effect Of Potent P2Y12 Inhibitors On Safety And Efficacy Of Bivalirudin Compared To Heparin In Acute Coronary Syndrome: A Meta-Analysis Of Randomized Controlled Trials Journal of the American College of Cardiology. 71. DOI: 10.1016/S0735-1097(18)31938-7 |
0.371 |
|
| 2018 |
Hawatmeh A, Thawabi M, Aggarwal R, Vavilin I, Balasubramaniapandian CA, Wasty N, Visveswaran G, Cohen M. TCT-785 Misclassification of Type 2 Myocardial Infarction and its Implication on Outcomes Journal of the American College of Cardiology. 72. DOI: 10.1016/J.Jacc.2018.08.2017 |
0.33 |
|
| 2017 |
Garg A, Raheja H, Cohen M. Coronary artery bypass grafting versus percutaneous coronary intervention in complex coronary artery disease: looking beyond clinical end-points. Annals of Translational Medicine. 5: 491. PMID 29299453 DOI: 10.21037/Atm.2017.10.05 |
0.365 |
|
| 2017 |
Cavallari I, Morrow DA, Creager MA, Olin J, Bhatt DL, Steg PG, Storey RF, Cohen M, Scirica BS, Piazza G, Goodrich EL, Braunwald E, Sabatine MS, Bonaca MP. Frequency, Predictors and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients with Symptomatic Atherosclerosis. Circulation. PMID 29084737 DOI: 10.1161/Circulationaha.117.031062 |
0.356 |
|
| 2017 |
Deharo P, Ducrocq G, Bode C, Cohen M, Cuisset T, Mehta S, Pollack CV, Wiviott SD, Elbez Y, Sabatine M, Steg PG. Timing of Angiography and Outcomes in High-Risk Patients with Non-ST Segment Elevation Myocardial Infarction Managed Invasively: Insights from the TAO Trial. Circulation. PMID 28893843 DOI: 10.1161/Circulationaha.117.029779 |
0.402 |
|
| 2017 |
Magnuson EA, Li H, Wang K, Vilain K, Shafiq A, Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Braunwald E, Sabatine MS, Cohen DJ. Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial. Journal of the American College of Cardiology. 70: 527-538. PMID 28750695 DOI: 10.1016/J.Jacc.2017.05.063 |
0.37 |
|
| 2017 |
Barvalia M, Thawabi M, Nawaz Y, Sethi N, Shao J, Amponsah M, Visveswaran G, Cohen M, Wasty N. Jetstream atherectomy and balloon angioplasty with distal embolic protection for Angio-Seal related vascular access complications. Cardiovascular Intervention and Therapeutics. PMID 28660560 DOI: 10.1007/S12928-017-0478-5 |
0.348 |
|
| 2017 |
Garg A, Rao SV, Agrawal S, Theodoropoulos K, Mennuni M, Sharma A, Garg L, Ferrante G, Meelu OA, Sargsyan D, Reimers B, Cohen M, Kostis JB, Stefanini GG. Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease. The American Journal of Cardiology. PMID 28433215 DOI: 10.1016/J.Amjcard.2017.03.019 |
0.4 |
|
| 2017 |
Hawatmeh A, Thawabi M, Abuarqoub A, Khaddash I, Studyvin S, Habib M, Shamoon F, Cohen M. Statins Use And Long Term Outcome Post Surgical Aortic Valve Replacement Journal of the American College of Cardiology. 69: 1979. DOI: 10.1016/S0735-1097(17)35368-8 |
0.327 |
|
| 2017 |
Verma DR, Pershad A, Morse M, Morris M, Gellert G, Okoh A, Cohen M, Lotun K, Dhoble A, Smalling R, Russo M, Kar S, Nakajima Y, Barker C, Moualla S, et al. TCT-465 A US Multicenter Registry For Percutaneous Transcatheter Mitral Valve Replacement Using Balloon Expandable Valve In Patients Who Are At Prohibitive Risk For Surgery Journal of the American College of Cardiology. 70: B192. DOI: 10.1016/J.Jacc.2017.09.576 |
0.315 |
|
| 2017 |
Verma DR, Pershad A, Morse M, Kar S, Morris M, Gellert G, Whisenant B, Lotun K, Nakajima Y, Barker C, Smalling R, Dhoble A, Querrey T, Okoh A, Chen C, ... ... Cohen M, et al. TCT-464 Percutaneous Transcatheter Mitral Valve Replacement via Transseptal or Transapical Approach In Patients Who Are Prohibitive Risk For Surgery: US Multicenter Registry Journal of the American College of Cardiology. 70: B191-B192. DOI: 10.1016/J.Jacc.2017.09.575 |
0.315 |
|
| 2017 |
Garg A, Arora A, Tsangaris A, Agrawal S, Garg L, Cohen M. TCT-149 Early Invasive versus Initial Conservative strategy in patients with Non-ST Elevation Acute Coronary Syndrome: A meta-analysis of randomized control trials Journal of the American College of Cardiology. 70. DOI: 10.1016/J.Jacc.2017.09.212 |
0.376 |
|
| 2016 |
Gibson CM, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Birmingham M, Ianus J, Burton P, van Eickels M, Korjian S, Daaboul Y, Lip GY, Cohen M, Husted S, et al. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. The New England Journal of Medicine. PMID 27959713 DOI: 10.1056/Nejmoa1611594 |
0.344 |
|
| 2016 |
Gibson CM, Pinto DS, Chi G, Arbetter D, Yee M, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Burton P, van Eickels M, Korjian S, Daaboul Y, Jain P, ... ... Cohen M, et al. Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy. Circulation. PMID 27881555 DOI: 10.1161/Circulationaha.116.025783 |
0.333 |
|
| 2016 |
Wasty N, Khakwani MZ, Kotev S, Boiangiu C, Hasan O, Anna M, Tayal R, Kaid K, Baker G, Cohen M. Ubiquitous Nature of Distal Athero/Thromboembolic Events during Lower Extremity Atherectomy Procedures Involving the Superficial Femoral Artery. The International Journal of Angiology : Official Publication of the International College of Angiology, Inc. 25: 252-257. PMID 27867291 DOI: 10.1055/S-0036-1587694 |
0.335 |
|
| 2016 |
Bonaca MP, Goto S, Bhatt DL, Steg PG, Storey RF, Cohen M, Goodrich E, Mauri L, Ophuis TO, Ruda M, Spinar J, Seung KB, Hu DY, Dalby AJ, Jensen EC, et al. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54). Circulation. PMID 27576775 DOI: 10.1161/Circulationaha.116.024637 |
0.361 |
|
| 2016 |
Vaduganathan M, Bhatt DL, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Cannon CP. Reply: High Risk of Gastrointestinal Bleeding on Dual Antiplatelet Treatment. Journal of the American College of Cardiology. 68: 981-2. PMID 27561775 DOI: 10.1016/J.Jacc.2016.06.008 |
0.318 |
|
| 2016 |
Shah R, Clare RM, Chiswell K, Jones WS, Kumar AS, Thiele H, Smalling RW, Chandra P, Cohen M, Perera D, Chew DP, French JK, Blaxill J, Ohman EM, Patel MR. Impact of Non-Infarct-Related Artery Disease on Infarct Size and Outcomes (from the CRISP-AMI Trial). The American Journal of Medicine. PMID 27542611 DOI: 10.1016/J.Amjmed.2016.07.011 |
0.378 |
|
| 2016 |
Bonaca MP, Bhatt DL, Oude Ophuis T, Steg PG, Storey R, Cohen M, Kuder J, Im K, Magnani G, Budaj A, Theroux P, Hamm C, Špinar J, Kiss RG, Dalby AJ, et al. Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial. Jama Cardiology. 1: 425-432. PMID 27438319 DOI: 10.1001/Jamacardio.2016.1017 |
0.359 |
|
| 2016 |
Vaduganathan M, Cannon CP, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Bhatt DL. Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial. The American Journal of Medicine. PMID 27143321 DOI: 10.1016/J.Amjmed.2016.03.042 |
0.367 |
|
| 2016 |
Tayal R, Iftikhar H, LeSar B, Patel R, Tyagi N, Cohen M, Wasty N. CT Angiography Analysis of Axillary Artery Diameter versus Common Femoral Artery Diameter: Implications for Axillary Approach for Transcatheter Aortic Valve Replacement in Patients with Hostile Aortoiliac Segment and Advanced Lung Disease. International Journal of Vascular Medicine. 2016: 3610705. PMID 27110403 DOI: 10.1155/2016/3610705 |
0.319 |
|
| 2016 |
Bonaca MP, Bhatt DL, Storey RF, Steg PG, Cohen M, Kuder J, Goodrich E, Nicolau JC, Parkhomenko A, López-Sendón J, Dellborg M, Dalby A, Špinar J, Aylward P, Corbalán R, et al. Efficacy and Safety of Ticagrelor as Long-Term Secondary Prevention in Patients with Peripheral Artery Disease and Prior Myocardial Infarction. Journal of the American College of Cardiology. PMID 27046162 DOI: 10.1016/J.Jacc.2016.03.524 |
0.402 |
|
| 2016 |
Bhatt DL, Bonaca MP, Bansilal S, Angiolillo DJ, Cohen M, Storey RF, Im K, Murphy SA, Held P, Braunwald E, Sabatine MS, Steg PG. Reduction in Ischemic Events with Ticagrelor in Diabetic Patients: From the PEGASUS-TIMI 54 Trial. Journal of the American College of Cardiology. PMID 27046160 DOI: 10.1016/J.Jacc.2016.03.529 |
0.346 |
|
| 2016 |
Vaduganathan M, Bhatt DL, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Cannon CP. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy. Journal of the American College of Cardiology. PMID 27012778 DOI: 10.1016/J.Jacc.2015.12.068 |
0.318 |
|
| 2016 |
Kohl LP, Leimberger JD, Chiswell K, Jones WS, Thiele H, Smalling RW, Chandra P, Cohen M, Perera D, Chew DP, French JK, Blaxil J, Kumar AS, Ohman EM, Patel MR. Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial. American Heart Journal. 174: 7-13. PMID 26995364 DOI: 10.1016/J.Ahj.2015.12.004 |
0.409 |
|
| 2016 |
Storey RF, Angiolillo DJ, Bonaca MP, Thomas MR, Judge HM, Rollini F, Franchi F, Ahsan AJ, Bhatt DL, Kuder JF, Steg PG, Cohen M, Muthusamy R, Braunwald E, Sabatine MS. Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial. Journal of the American College of Cardiology. 67: 1145-54. PMID 26965534 DOI: 10.1016/J.Jacc.2015.12.062 |
0.328 |
|
| 2016 |
Liu Z, Silvain J, Kerneis M, Barthélémy O, Payot L, Choussat R, Sabouret P, Cohen M, Pollack CV, Goldstein P, Zeymer U, Huber K, Vicaut E, Collet JP, Montalescot G. Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL Trial. Angiology. PMID 26861858 DOI: 10.1177/0003319716629541 |
0.439 |
|
| 2016 |
Bonaca MP, Bhatt D, Storey R, Steg P, Cohen M, Kuder J, Im K, Held P, Jensen E, Braunwald E, Sabatine M. EFFICACY AND SAFETY OF TICAGRELOR AS LONG-TERM SECONDARY PREVENTION IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION AND PERIPHERAL ARTERY DISEASE Journal of the American College of Cardiology. 67: 2266. DOI: 10.1016/S0735-1097(16)32267-7 |
0.351 |
|
| 2016 |
Bhatt DL, Bonaca M, Bansilal S, Cohen M, Storey RF, Im K, Murphy S, Held P, Braunwald E, Sabatine M, Steg PG. REDUCTION IN ISCHEMIC EVENTS WITH TICAGRELOR IN DIABETIC PATIENTS FROM THE PEGASUS-TIMI 54 TRIAL Journal of the American College of Cardiology. 67: 2111. DOI: 10.1016/S0735-1097(16)32112-X |
0.312 |
|
| 2016 |
Visveswaran GK, Gidea C, Baran D, Cohen M, Zucker MJ. Acute left ventricular dysfunction complicating pregnancy on ECMO: Tri-iodothyronine to the rescue with real time transesophageal echocardiography Journal of Cardiology Cases. 13: 33-36. DOI: 10.1016/J.Jccase.2015.09.005 |
0.303 |
|
| 2016 |
Barvalia M, Tcharnaia L, Szymanski J, Baran N, Cohen M. High Lipoprotein (a) In A Patient With Coronary Artery Disease And Venous Thromboembolism Journal of Clinical Lipidology. 10: 655. DOI: 10.1016/J.Jacl.2016.03.014 |
0.335 |
|
| 2015 |
Bonaca MP, Bhatt DL, Steg PG, Storey RF, Cohen M, Im K, Oude Ophuis T, Budaj A, Goto S, López-Sendón J, Diaz R, Dalby A, Van de Werf F, Ardissino D, Montalescot G, et al. Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. European Heart Journal. PMID 26491109 DOI: 10.1093/Eurheartj/Ehv531 |
0.363 |
|
| 2015 |
Pellaton C, Cayla G, Silvain J, Zeymer U, Cohen M, Goldstein P, Huber K, Pollack C, Kerneis M, Collet JP, Vicaut E, Montalescot G. Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial. American Heart Journal. 170: 778-86. PMID 26386802 DOI: 10.1016/J.Ahj.2015.05.021 |
0.412 |
|
| 2015 |
Vardi M, Cryer BL, Cohen M, Lanas A, Schnitzer TJ, Lapuerta P, Goldsmith MA, Laine L, Doros G, Liu Y, McIntosh AI, Cannon CP, Bhatt DL. The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial. Alimentary Pharmacology & Therapeutics. 42: 365-74. PMID 26032114 DOI: 10.1111/Apt.13260 |
0.336 |
|
| 2015 |
Cohen M. Long-term outcomes in high-risk patients with non-ST-segment elevation myocardial infarction. Journal of Thrombosis and Thrombolysis. PMID 26001907 DOI: 10.1007/S11239-015-1227-1 |
0.425 |
|
| 2015 |
Gibson CM, Mehran R, Bode C, Halperin J, Verheugt F, Wildgoose P, van Eickels M, Lip GY, Cohen M, Husted S, Peterson E, Fox K. An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). American Heart Journal. 169: 472-8.e5. PMID 25819853 DOI: 10.1016/J.Ahj.2014.12.006 |
0.392 |
|
| 2015 |
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, et al. Long-term use of ticagrelor in patients with prior myocardial infarction. The New England Journal of Medicine. 372: 1791-800. PMID 25773268 DOI: 10.1056/Nejmoa1500857 |
0.384 |
|
| 2015 |
Wang L, Zucker MJ, Cohen M, Baran DA, Camacho M, Gidea C, Zheng H, Amponsah M, Chen C. Pre-operative Speckle-tracking Imaging to Predict the Need for Right Ventricular Support in Patients Undergoing Left Ventricular Assist Device Implantation Journal of Cardiovascular Disease Research. 6: 1-11. DOI: 10.5530/Jcdr.2015.1.1 |
0.316 |
|
| 2014 |
Barvalia M, Silber D, DiVita M, Joshi A, Wasty N, Cohen M. Utility of carotid duplex ultrasonography in a general inner-city hospital. Cardiovascular Ultrasound. 12: 48. PMID 25422167 DOI: 10.1186/1476-7120-12-48 |
0.313 |
|
| 2014 |
Cohen M, Iyer D. The "dual-pathway" strategy after acute coronary syndrome: rivaroxaban and antiplatelet agents in the ATLAS ACS 2-TIMI 51 trial. Cardiovascular Therapeutics. 32: 224-32. PMID 24894120 DOI: 10.1111/1755-5922.12083 |
0.424 |
|
| 2014 |
Bonaca MP, Bhatt DL, Braunwald E, Cohen M, Steg PG, Storey RF, Held P, Jensen EC, Sabatine MS. Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial. American Heart Journal. 167: 437-444.e5. PMID 24655690 DOI: 10.1016/J.Ahj.2013.12.020 |
0.394 |
|
| 2013 |
Collet JP, Huber K, Cohen M, Zeymer U, Goldstein P, Pollack C, Silvain J, Henry P, Varenne O, Carrié D, Coste P, Angioi M, Le Breton H, Cayla G, Elhadad S, et al. A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial). The American Journal of Cardiology. 112: 1367-72. PMID 24012033 DOI: 10.1016/J.Amjcard.2013.07.003 |
0.403 |
|
| 2013 |
Steg PG, Mehta SR, Pollack CV, Bode C, Cohen M, French WJ, Hoekstra J, Rao SV, Ruzyllo W, Ruiz-Nodar JM, Sabaté M, Widimsky P, Kiss RG, Navarro Estrada JL, Hod H, et al. Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial. Jama. 310: 1145-55. PMID 23995608 DOI: 10.1001/Jama.2013.277165 |
0.431 |
|
| 2013 |
Gibson CM, Chakrabarti AK, Mega J, Bode C, Bassand JP, Verheugt FW, Bhatt DL, Goto S, Cohen M, Mohanavelu S, Burton P, Stone G, Braunwald E. Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. Journal of the American College of Cardiology. 62: 286-90. PMID 23602776 DOI: 10.1016/J.Jacc.2013.03.041 |
0.392 |
|
| 2013 |
Iqbal Z, Cohen M, Pollack C, Goldstein P, Zeymer U, Huber K, Barthelemy O, Cayla G, Aout M, Vicaut E, Montalescot G. Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarction. The American Journal of Cardiology. 111: 1727-33. PMID 23528027 DOI: 10.1016/J.Amjcard.2013.02.020 |
0.446 |
|
| 2013 |
Yaganti V, Mejevoi N, Hasan O, Cohen M, Wasty N. Pitfalls associated with the use of current recommendations for fluoroscopy-guided common femoral artery access. Catheterization and Cardiovascular Interventions. 81: 674-679. PMID 23292908 DOI: 10.1002/Ccd.24335 |
0.332 |
|
| 2013 |
Lin J, Kuhel WI, Parashar B, Voigt EP, Cohen MA, Kutler DI. Treatment of Cutaneous Head and Neck Squamous Cell Carcinoma Metastatic to the Parotid Gland Otolaryngology-Head and Neck Surgery. 149. DOI: 10.1177/0194599813496044A175 |
0.324 |
|
| 2013 |
Cohen M, Hoekstra J, Pollack CV. Casebook Challenges: Individualizing Antiplatelet Therapy in the Emergency Department – Dialogue with the Experts Journal of Emergency Medicine. 44: 1054. DOI: 10.1016/J.Jemermed.2013.02.019 |
0.377 |
|
| 2012 |
Iqbal Z, Rana G, Cohen M. Appropriate anti-thrombotic/anti-thrombin therapy for thrombotic lesions. Current Cardiology Reviews. 8: 181-191. PMID 22920489 DOI: 10.2174/157340312803217175 |
0.368 |
|
| 2012 |
Cohen M. Improving long-term ACS management: Is there a role for the new antiplatelets? Journal of Interventional Cardiology. 25: 425-432. PMID 22574644 DOI: 10.1111/J.1540-8183.2012.00738.X |
0.378 |
|
| 2012 |
Thomas MP, Mahaffey KW, Chiswell K, Cohen M, Kontos MC, Antman EM, Ferguson JJ, Califf RM, Goodman SG, Becker RC. Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin. Journal of Thrombosis and Thrombolysis. 34: 114-9. PMID 22323092 DOI: 10.1007/S11239-012-0693-Y |
0.432 |
|
| 2012 |
Silvain J, Beygui F, Barthélémy O, Pollack C, Cohen M, Zeymer U, Huber K, Goldstein P, Cayla G, Collet JP, Vicaut E, Montalescot G. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. Bmj (Clinical Research Ed.). 344: e553. PMID 22306479 DOI: 10.1136/Bmj.E553 |
0.324 |
|
| 2012 |
Cohen M, Jeske WP, Nicolau JC, Montalescot G, Fareed J. US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins. Journal of Thrombosis and Thrombolysis. 33: 230-8. PMID 22234748 DOI: 10.1007/S11239-012-0680-3 |
0.302 |
|
| 2012 |
Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, et al. Rivaroxaban in patients with a recent acute coronary syndrome. The New England Journal of Medicine. 366: 9-19. PMID 22077192 DOI: 10.1056/Nejmoa1112277 |
0.34 |
|
| 2011 |
Cohen M, Boiangiu C. The management of patients with atrial fibrillation and dronedarone's place in therapy Advances in Therapy. 28: 1059-1077. PMID 22170292 DOI: 10.1007/S12325-011-0086-1 |
0.309 |
|
| 2011 |
Patel MR, Smalling RW, Thiele H, Barnhart HX, Zhou Y, Chandra P, Chew D, Cohen M, French J, Perera D, Ohman EM. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. Jama. 306: 1329-37. PMID 21878431 DOI: 10.1001/Jama.2011.1280 |
0.373 |
|
| 2011 |
Patel MR, Thiele H, Smalling RW, Chandra P, Zhou Y, Cohen M, Perera D, Ohman EM. A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: Rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial American Heart Journal. 162: 47-55.e1. PMID 21742089 DOI: 10.1016/J.Ahj.2011.03.037 |
0.371 |
|
| 2011 |
Leibowitz JM, Smith LP, Cohen MA, Dunham BP, Guttenberg M, Elden LM. Diagnosis and treatment of pediatric vallecular cysts and pseudocysts. International Journal of Pediatric Otorhinolaryngology. 75: 899-904. PMID 21531029 DOI: 10.1016/J.Ijporl.2011.03.032 |
0.324 |
|
| 2011 |
Iqbal Z, Cohen M. Enoxaparin: A pharmacologic and clinical review Expert Opinion On Pharmacotherapy. 12: 1157-1170. PMID 21470072 DOI: 10.1517/14656566.2011.570261 |
0.308 |
|
| 2011 |
Mahaffey KW, Pieper KS, Lokhnygina Y, Califf RM, Antman EM, Kleiman NS, Goodman SG, White HD, Rao SV, Hochman JS, Cohen M, Col JJ, Roe MT, Ferguson JJ. The impact of postrandomization crossover of therapy in acute coronary syndromes care. Circulation. Cardiovascular Quality and Outcomes. 4: 211-9. PMID 21304094 DOI: 10.1161/Circoutcomes.109.853598 |
0.37 |
|
| 2011 |
Giugliano RP, Pollack CV, Brogan GX, Cohen M, Diercks DB, Grines CL, Henry TD, Kleiman NS. Acute coronary syndromes: From the emergency department to the catheterization laboratory - Integrating evidence from recent ACS/NSTEMI trials into clinical practice: An evidence-based review of recent clinical trial results and report on a roundtable discussion Journal of Interventional Cardiology. 24: 119-136. PMID 21114529 DOI: 10.1111/J.1540-8183.2010.00607.X |
0.332 |
|
| 2011 |
Montalescot G, Salette G, Steg G, Cohen M, White HD, Gallo R, Steinhubl SR. Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention International Journal of Cardiology. 150: 79-83. PMID 20299114 DOI: 10.1016/J.Ijcard.2010.02.077 |
0.383 |
|
| 2010 |
Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP. Clopidogrel with or without omeprazole in coronary artery disease. The New England Journal of Medicine. 363: 1909-17. PMID 20925534 DOI: 10.1056/Nejmoa1007964 |
0.37 |
|
| 2010 |
Iqbal Z, Cohen M. Emerging antithrombotic agents: What does the intensivist need to know? Current Opinion in Critical Care. 16: 419-425. PMID 20802329 DOI: 10.1097/Mcc.0B013E32833E1092 |
0.307 |
|
| 2010 |
Cohen M, Levine GN, Pieper KS, Lan L, Antman EM, Aylward PE, White HD, Kleiman NS, Califf RM, Mahaffey KW. Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 75: 928-35. PMID 20432399 DOI: 10.1002/Ccd.22340 |
0.396 |
|
| 2010 |
Cohen M, Boiangiu C, Abidi M. Therapy for ST-Segment Elevation Myocardial Infarction Patients Who Present Late or Are Ineligible for Reperfusion Therapy Journal of the American College of Cardiology. 55: 1895-1906. PMID 20430260 DOI: 10.1016/J.Jacc.2009.11.087 |
0.396 |
|
| 2010 |
Cohen M. The thrombin hypothesis in ACS: a disappointing disconnect between bench data and bedside clinical trials. The American Journal of Medicine. 123: 103-110. PMID 20103015 DOI: 10.1016/J.Amjmed.2009.09.001 |
0.357 |
|
| 2010 |
Spinler SA, Mahaffey KW, Gallup D, Levine GN, Ferguson JJ, Rao SV, Gallo R, Ducas J, Goodman SG, Antman E, White HD, Biasucci L, Becker RC, Col JJ, Cohen M, et al. Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. International Journal of Cardiology. 144: 36-41. PMID 19406493 DOI: 10.1016/J.Ijcard.2009.03.119 |
0.384 |
|
| 2010 |
Khoobiar S, VanHise A, Apolito R, Cohen M. Interatrial thrombus-in-transit resulting in paradoxical thromboembolism Journal of Thrombosis and Thrombolysis. 29: 127-129. PMID 19294335 DOI: 10.1007/S11239-009-0317-3 |
0.342 |
|
| 2010 |
Jarreau T, Khoobiar S, Setty S, Cohen M, Chen C. Significant Coronary Artery Disease in Patients with a Negative Calcium Scan and Suspicious Ischemic Heart Disease in a Racially Diverse Patient Population~!2009-10-05~!2010-01-26~!2010-06-08~! The Open Cardiovascular Imaging Journal. 2: 3-9. DOI: 10.2174/1876538601002010003 |
0.326 |
|
| 2010 |
Cohen M, Boiangiu C, Abidi M, Chipigina NS. Therapy For St-Segment Elevation Myocardial Infarction Patients Who Present Late Or Are Ineligible For Reperfusion RacionalʹNaâ Farmakoterapiâ V Kardiologii. 6: 888-901. DOI: 10.20996/1819-6446-2010-6-6-888-901 |
0.352 |
|
| 2009 |
Montalescot G, Gallo R, White HD, Cohen M, Steg PG, Aylward PEG, Bode C, Chiariello M, King SB, Harrington RA, Desmet WJ, Macaya C, Steinhubl SR. Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention : 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial Jacc-Cardiovascular Interventions. 2: 1083-1091. PMID 19926048 DOI: 10.1016/J.Jcin.2009.08.016 |
0.408 |
|
| 2009 |
Cohen M. Oral antiplatelet therapy for acute and chronic management of NSTE ACS: residual ischemic risk and opportunities for improvement. Cardiovascular Drugs and Therapy. 23: 489-499. PMID 19890703 DOI: 10.1007/S10557-009-6204-5 |
0.351 |
|
| 2009 |
Hoekstra J, Cohen M, Giugliano R, Granger CB, Gurbel PA, Hollander JE, Manoukian SV, Saucedo JF, Pollack CV. Expert consensus on treatment strategies in non- ST-segment elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention--an evidence-based review of clinical trial results and treatment guidelines from an emergency medicine perspective: report on a roundtable discussion. The American Journal of Emergency Medicine. 27: 720-8. PMID 19757551 DOI: 10.1016/J.Ajem.2008.04.032 |
0.387 |
|
| 2009 |
Cohen M. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond. Catheterization and Cardiovascular Interventions. 74: 579-597. PMID 19472347 DOI: 10.1002/Ccd.22021 |
0.394 |
|
| 2009 |
Díez JG, Cohen M. Balancing Myocardial Ischemic and Bleeding Risks in Patients With Non-ST-Segment Elevation Myocardial Infarction American Journal of Cardiology. 103: 1396-1402. PMID 19427435 DOI: 10.1016/J.Amjcard.2009.01.349 |
0.329 |
|
| 2009 |
Nicolau JC, Cohen M, Montalescot G. Differences among low-molecular-weight heparins: evidence in patients with acute coronary syndromes. Journal of Cardiovascular Pharmacology. 53: 440-445. PMID 19365279 DOI: 10.1097/Fjc.0B013E3181A59Abc |
0.383 |
|
| 2009 |
Cohen MA, Liang J, Cohen IJ, Grady MS, O'Malley BW, Newman JG. Endoscopic resection of advanced anterior skull base lesions: oncologically safe? Orl; Journal For Oto-Rhino-Laryngology and Its Related Specialties. 71: 123-8. PMID 19321974 DOI: 10.1159/000209312 |
0.314 |
|
| 2009 |
Hoekstra J, Cohen M. Management of patients with unstable angina / non-ST-elevation myocardial infarction: a critical review of the 2007 ACC /AHA guidelines. International Journal of Clinical Practice. 63: 642-655. PMID 19222616 DOI: 10.1111/J.1742-1241.2009.01998.X |
0.386 |
|
| 2009 |
White HD, Gallo R, Cohen M, Steg PG, Aylward PE, Bode C, Steinhubl S, Montalescot G. The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment: results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial. American Heart Journal. 157: 125-131. PMID 19081408 DOI: 10.1016/J.Ahj.2008.08.019 |
0.344 |
|
| 2009 |
Cohen M, Ferguson JJ. Re-evaluating risk factors for periprocedural complications during percutaneous coronary intervention in patients with unstable angina/non-ST-elevation myocardial infarction: who may benefit from more intensive antiplatelet therapy? Current Opinion in Cardiology. 24: 88-94. PMID 19077819 DOI: 10.1097/Hco.0B013E32831Ac90B |
0.424 |
|
| 2009 |
Cohen M. Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care. Mayo Clinic Proceedings. 84: 149-160. DOI: 10.4065/84.2.149 |
0.341 |
|
| 2008 |
Cohen MA, Liang J, O'Malley BW, Newman JG. Endoscopic Margins of Skull-base Tumors: Oncologically Safe? Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 139: P37. PMID 29400181 DOI: 10.1016/J.Otohns.2008.05.121 |
0.309 |
|
| 2008 |
O'Malley BW, Grady MS, Gabel BC, Cohen MA, Heuer GG, Pisapia J, Bohman LE, Leibowitz JM. Comparison of endoscopic and microscopic removal of pituitary adenomas: single-surgeon experience and the learning curve. Neurosurgical Focus. 25: E10. PMID 19035697 DOI: 10.3171/Foc.2008.25.12.E10 |
0.314 |
|
| 2008 |
Cohen M, Hoekstra J. The use of adjunctive anticoagulants in patients with acute coronary syndrome transitioning to percutaneous coronary intervention. American Journal of Emergency Medicine. 26: 932-941. PMID 18926355 DOI: 10.1016/J.Ajem.2007.11.031 |
0.423 |
|
| 2008 |
Cohen M, Hoekstra J, Giugliano R, Granger CB, Gurbel PA, Hollander JE, Manoukian SV, Pollack CV, Saucedo JF. Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussion. Journal of Interventional Cardiology. 21: 283-99. PMID 18754964 DOI: 10.1111/J.1540-8183.2008.00375.X |
0.369 |
|
| 2008 |
Khoobiar S, Mejevoi N, Kaid K, Boiangiu C, Setty S, Tanwir A, Khalid K, Cohen M. Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen. Journal of Thrombosis and Thrombolysis. 26: 85-90. PMID 18636227 DOI: 10.1007/S11239-008-0258-2 |
0.41 |
|
| 2008 |
Cohen M. High-risk Acute Coronary Syndrome Patients with Non-ST-Elevation Myocardial Infarction: Definition and Treatment Cardiovascular Drugs and Therapy. 22: 407-418. PMID 18592363 DOI: 10.1007/S10557-008-6120-0 |
0.399 |
|
| 2008 |
Leung S, Gallup D, Mahaffey KW, Cohen M, Antman EM, Goodman SG, Harrington RA, Langer A, Aylward P, Ferguson JJ, Califf RM. Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome. American Heart Journal. 156: 177-84. PMID 18585514 DOI: 10.1016/J.Ahj.2008.02.002 |
0.313 |
|
| 2008 |
Montalescot G, Cohen M, Salette G, Desmet WJ, Macaya C, Aylward PEG, Steg PG, White HD, Gallo R, Steinhubl SR. Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial European Heart Journal. 29: 462-471. PMID 18276619 DOI: 10.1093/Eurheartj/Ehn008 |
0.375 |
|
| 2008 |
Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, Col JJ, Reist C, Ferguson JJ, Califf RM. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. Journal of General Internal Medicine. 23: 310-6. PMID 18196350 DOI: 10.1007/S11606-007-0498-4 |
0.405 |
|
| 2008 |
Cohen M, Alexander KP, Rao SV. Bleeding after antithrombotic therapy in patients with acute ischemic heart disease Journal of Thrombosis and Thrombolysis. 26: 175-182. PMID 18080799 DOI: 10.1007/S11239-007-0182-X |
0.371 |
|
| 2007 |
Cohen M, Roubin G, Kuepper F. The challenge of ST-segment elevation myocardial infarction. International Journal of Clinical Practice. 61: 2079-2092. PMID 17941831 DOI: 10.1111/J.1742-1241.2007.01601.X |
0.415 |
|
| 2007 |
Murphy SA, Gibson CM, Morrow DA, Werf FVd, Menown IB, Goodman SG, Mahaffey KW, Cohen M, McCabe CH, Antman EM, Braunwald E. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. European Heart Journal. 28: 2077-2086. PMID 17600038 DOI: 10.1093/Eurheartj/Ehm224 |
0.406 |
|
| 2007 |
Gibson CM, Murphy SA, Montalescot G, Morrow DA, Ardissino D, Cohen M, Gulba DC, Kracoff OH, Lewis BS, Roguin N, Antman EM, Braunwald E. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. Journal of the American College of Cardiology. 49: 2238-46. PMID 17560287 DOI: 10.1016/J.Jacc.2007.01.093 |
0.396 |
|
| 2007 |
Cohen M, Bhatt DL, Alexander JH, Montalescot G, Bode C, Henry T, Tamby JF, Saaiman J, Simek S, De Swart J. Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trial. Circulation. 115: 2642-51. PMID 17502577 DOI: 10.1161/Circulationaha.106.653428 |
0.354 |
|
| 2007 |
Cantor WJ, Mahaffey KW, Huang Z, Das P, Gulba DC, Glezer S, Gallo R, Ducas J, Cohen M, Antman EM, Langer A, Kleiman NS, White HD, Chisholm RJ, Harrington RA, et al. Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal Catheterization and Cardiovascular Interventions. 69: 73-83. PMID 17139670 DOI: 10.1002/Ccd.20897 |
0.388 |
|
| 2006 |
White HD, Kleiman NS, Mahaffey KW, Lokhnygina Y, Pieper KS, Chiswell K, Cohen M, Harrington RA, Chew DP, Petersen JL, Berdan LG, Aylward PE, Nessel CC, Ferguson JJ, Califf RM. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial. American Heart Journal. 152: 1042-50. PMID 17161049 DOI: 10.1016/J.Ahj.2006.08.002 |
0.429 |
|
| 2006 |
Cohen M, Mahaffey KW, Pieper K, Pollack CV, Antman EM, Hoekstra J, Goodman SG, Langer A, Col JJ, White HD, Califf RM, Ferguson JJ. A Subgroup Analysis of the Impact of Prerandomization Antithrombin Therapy on Outcomes in the SYNERGY Trial. Enoxaparin Versus Unfractionated Heparin in Non-ST-Segment Elevation Acute Coronary Syndromes Journal of the American College of Cardiology. 48: 1346-1354. PMID 17010793 DOI: 10.1016/J.Jacc.2006.05.058 |
0.392 |
|
| 2006 |
Montalescot G, White HD, Gallo R, Cohen M, Steg PG, Aylward PEG, Bode C, Chiariello M, King SB, Harrington RA, Desmet WJ, Macaya C, Steinhubl SR. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. The New England Journal of Medicine. 355: 1006-1017. PMID 16957147 DOI: 10.1056/Nejmoa052711 |
0.304 |
|
| 2006 |
Spyropoulos AC, Bauersachs RM, Omran H, Cohen M. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Current Medical Research and Opinion. 22: 1109-1122. PMID 16846544 DOI: 10.1185/030079906X104858 |
0.355 |
|
| 2006 |
El Rouby S, Cohen M, Gonzales A, Hoppensteadt D, Lee T, Zucker ML, Khalid K, Laduca FM, Fareed J. The use of a HEMOCHRON JR. HEMONOX point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures. Journal of Thrombosis and Thrombolysis. 21: 137-45. PMID 16622609 DOI: 10.1007/S11239-006-4383-5 |
0.344 |
|
| 2006 |
Goodman SG, Bozovich GE, Tan M, Santos AD, Gurfinkel EP, Cohen M, Langer A. The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: The Enoxaparin in Non–Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy American Heart Journal. 151: 791-797. PMID 16569535 DOI: 10.1016/J.Ahj.2005.08.007 |
0.388 |
|
| 2006 |
Cohen M, Singh D. At six months, enoxaparin is more effective than tinzaparin for people with non ST-segment elevation acute coronary syndromes. Evidence-Based Cardiovascular Medicine. 10: 30-31. PMID 16530671 DOI: 10.1016/J.Ebcm.2006.01.017 |
0.343 |
|
| 2005 |
Mustafa MU, Cohen M, Zapotulko K, Feinberg M, Miller MF, Aueron F, Wasty N, Tanwir A, Rogal G. The lack of a simple relation between physician's percutaneous coronary intervention volume and outcomes in the era of coronary stenting: a two-centre experience. International Journal of Clinical Practice. 59: 1401-7. PMID 16351671 DOI: 10.1111/J.1368-5031.2005.00707.X |
0.365 |
|
| 2005 |
Mahaffey KW, Cohen M, Garg J, Antman E, Kleiman NS, Goodman SG, Berdan LG, Reist CJ, Langer A, White HD, Aylward PE, Col JJ, Ferguson JJ, Califf RM. High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin - Outcomes at 6 months and 1 year in the SYNERGY trial Jama. 294: 2594-2600. PMID 16304073 DOI: 10.1001/Jama.294.20.2594 |
0.4 |
|
| 2005 |
Cohen M, Gensini GF, Maritz F, Gurfinkel EP, Huber K, Timerman A, Santopinto J, Corsini G, Terrosu P, Joulain F. The role of gender and other factors as predictors of not receiving reperfusion therapy and of outcome in ST-segment elevation myocardial infarction. Journal of Thrombosis and Thrombolysis. 19: 155-161. PMID 16082602 DOI: 10.1007/S11239-005-1524-1 |
0.37 |
|
| 2005 |
Cohen M. Low-molecular-weight heparin in patients with acute ST-segment elevation myocardial infarction The American Heart Hospital Journal. 3: 82-87. PMID 15860994 DOI: 10.1111/J.1541-9215.2005.04306.X |
0.407 |
|
| 2005 |
Cohen M. Predictors of bleeding risk and long-term mortality in patients with acute coronary syndromes Current Medical Research and Opinion. 21: 439-445. PMID 15811213 DOI: 10.1185/030079905X30725 |
0.358 |
|
| 2005 |
Rouby SE, Cohen M, Gonzales A, Hoppensteadt D, Zucker ML, Lee T, Khalid K, Fareed J, LaDuca FM. Point-of-Care Monitoring of Enoxaparin in the Presence of GpIIb/IIIa Combined Therapy During Percutaneous Coronary Interventions Point of Care: the Journal of Near-Patient Testing & Technology. 4: 30-35. DOI: 10.1097/01.Poc.0000157177.83327.3F |
0.326 |
|
| 2004 |
Petersen JL, Mahaffey KW, Becker RC, Goodman SG, Kleiman NS, Marian AJ, Stone GW, Lansky AJ, Lincoff AM, Hazen SL, Nessel CC, Toro-Figueroa L, Tate L, Reist CJ, Cohen M, et al. Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library. American Heart Journal. 148: 269-76. PMID 15308996 DOI: 10.1016/J.Ahj.2004.03.022 |
0.392 |
|
| 2004 |
Urban PM, Freedman RJ, Ohman EM, Stone GW, Christenson JT, Cohen M, Miller MF, Joseph DL, Bynum DZ, Ferguson JJ. In-hospital mortality associated with the use of intra-aortic balloon counterpulsation. The American Journal of Cardiology. 94: 181-5. PMID 15246896 DOI: 10.1016/J.Amjcard.2004.03.058 |
0.309 |
|
| 2004 |
Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, Lemos JAd, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. Jama. 292: 89-96. PMID 15238596 DOI: 10.1001/Jama.292.1.89 |
0.38 |
|
| 2004 |
Cohen M, Arjomand H, Pollack CV. The evolution of thrombolytic therapy and adjunctive antithrombotic regimens in acute ST-segment elevation myocardial infarction American Journal of Emergency Medicine. 22: 14-23. PMID 14724872 DOI: 10.1016/J.Ajem.2003.09.001 |
0.373 |
|
| 2004 |
Cohen M. Progress with diabetic patients undergoing percutaneous coronary intervention. European Heart Journal. 25: 99-100. PMID 14720523 DOI: 10.1016/J.Ehj.2003.11.001 |
0.321 |
|
| 2004 |
Rouby SE, Patel U, Patsh M, Cohen M, Zucker ML, Pan C, LaDuca FM. The Influence of Prior Oral Anticoagulation Therapy on the Anticoagulant Effect of Low Molecular Weight Heparin. Blood. 104: 4080-4080. DOI: 10.1182/Blood.V104.11.4080.4080 |
0.351 |
|
| 2004 |
Yan AT, Yan R, Tan M, Fitchett DH, Cohen M, Armstrong PW, Langer A, Goodman SG. 1097-98 Early continuous ST monitoring identifies acute coronary syndrome patients at high risk of death and myocardial infarction despite contemporary treatment Journal of the American College of Cardiology. 43. DOI: 10.1016/S0735-1097(04)91177-1 |
0.392 |
|
| 2003 |
Bijsterveld NR, Peters RJG, Murphy SA, Bernink PJLM, Tijssen JGP, Cohen M. Recurrent cardiac ischemic Events early after discontinuation of short-term heparin treatment in acute coronary syndromes: Results from the thrombolysis In Myocardial Infarction (TIMI) 11B and efficacy and safety of subcutaneous enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) studies Journal of the American College of Cardiology. 42: 2083-2089. PMID 14680731 DOI: 10.1016/J.Jacc.2003.05.014 |
0.386 |
|
| 2003 |
Cohen M, Gensini GF, Maritz F, Gurfinkel EP, Huber K, Timerman A, Krzeminska-Pakula M, Santopinto J, Hecquet C, Vittori L. Prospective Evaluation of Clinical Outcomes After Acute ST-Elevation Myocardial Infarction in Patients Who Are Ineligible for Reperfusion Therapy: Preliminary Results From the TETAMI Registry and Randomized Trial Circulation. 108: III14-III21. PMID 14605015 DOI: 10.1161/01.Cir.0000091832.74006.1C |
0.428 |
|
| 2003 |
Ferguson JJ, Antman EM, Bates ER, Cohen M, Every NR, Harrington RA, Pepine CJ, Theroux P. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. American Heart Journal. 146: 628-34. PMID 14564315 DOI: 10.1016/S0002-8703(03)00165-0 |
0.418 |
|
| 2003 |
Cohen M, Gensini GF, Maritz F, Gurfinkel EP, Huber K, Timerman A, Krzeminska-Pakula M, Danchin N, White HD, Santopinto J, Bigonzi F, Hecquet C, Vittori L. The Safety and Efficacy of Subcutaneous Enoxaparin Versus Intravenous Unfractionated Heparin and Tirofiban Versus Placebo in the Treatment of Acute ST-Segment Elevation Myocardial Infarction Patients Ineligible for Reperfusion (TETAMI): A Randomized Trial Journal of the American College of Cardiology. 42: 1348-1356. PMID 14563573 DOI: 10.1016/S0735-1097(03)01040-4 |
0.395 |
|
| 2003 |
Cohen M, Urban P, Christenson JT, Joseph DL, Freedman RJ, Miller MF, Ohman EM, Reddy RC, Stone GW, Ferguson JJ. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. European Heart Journal. 24: 1763-70. PMID 14522572 DOI: 10.1016/J.Ehj.2003.07.002 |
0.377 |
|
| 2003 |
Spinler SA, Inverso SM, Cohen M, Goodman SG, Stringer KA, Antman EM. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. American Heart Journal. 146: 33-41. PMID 12851605 DOI: 10.1016/S0002-8703(03)00121-2 |
0.337 |
|
| 2003 |
Stone GW, Ohman EM, Miller MF, Joseph DL, Christenson JT, Cohen M, Urban PM, Reddy RC, Freedman RJ, Staman KL, Ferguson JJ. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. Journal of the American College of Cardiology. 41: 1940-5. PMID 12798561 DOI: 10.1016/S0735-1097(03)00400-5 |
0.426 |
|
| 2003 |
Cohen M. The role of low-molecular-weight heparin in the management of acute coronary syndromes. Journal of the American College of Cardiology. 41: 55-61. PMID 12644342 DOI: 10.1016/S0735-1097(02)02901-7 |
0.409 |
|
| 2003 |
Bhatt DL, Lee BI, Casterella PJ, Pulsipher M, Rogers M, Cohen M, Corrigan VE, Ryan TJ, Breall JA, Moses JW, Eaton GM, Sklar MA, Lincoff AM. Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study. Journal of the American College of Cardiology. 41: 20-5. PMID 12570939 DOI: 10.1016/S0735-1097(02)02631-1 |
0.42 |
|
| 2003 |
Arjomand H, Willerson JT, Holmes DR, Roukoz B, Surabhi S, Dairywala I, Ahsan C, Cohen M, Turi ZG, Goldberg S. Clinical and angiographic predictors of cardiac events in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention in the current era: Insights from the PRESTO trial Journal of the American College of Cardiology. 41: 361. DOI: 10.1016/S0735-1097(03)82132-0 |
0.395 |
|
| 2003 |
Cohen M, Gensini GF, Maritz F, Gurfinkel EP, Huber K, Timerman A, Krzeminska-Pakula M, Danchin N, White HD, Vittori L. Underuse of reperfusion therapy in female patients: Insights from the TETAMI study and registry (The safety and efficacy of subcutaneous Enoxaparin versus intravenous unfractionated heparin and of myocardial infarction) Journal of the American College of Cardiology. 41: 358. DOI: 10.1016/S0735-1097(03)82118-6 |
0.364 |
|
| 2003 |
Gensini GF, Cohen M, Maritz F, Gurfinkel EP, Huber K, Timerman A, Krzeminska-Pakula M, Danchin N, White HD, Vittori L. Use of reperfusion therapy in patients presenting with ST elevation myocardial infarction: Findings from the TETAMI study and TETAMI registry (the safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in the treatment of acute myocardial infarction) Journal of the American College of Cardiology. 41: 377. DOI: 10.1016/S0735-1097(03)81068-9 |
0.383 |
|
| 2002 |
Cohen M. Defining optimal therapy for the thrombolysis-ineligible patient Clinical Cardiology. 25. PMID 12428816 DOI: 10.1002/Clc.4960251306 |
0.419 |
|
| 2002 |
Christenson JT, Cohen M, Ferguson JJ, Freedman RJ, Miller MF, Ohman EM, Reddy RC, Stone GW, Urban PM. Trends in intraaortic balloon counterpulsation complications and outcomes in cardiac surgery. The Annals of Thoracic Surgery. 74: 1086-90; discussion . PMID 12400750 DOI: 10.1016/S0003-4975(02)03854-7 |
0.35 |
|
| 2002 |
Kereiakes DJ, Montalescot G, Antman EM, Cohen M, Darius H, Ferguson JJ, Grines C, Karsch KR, Kleiman NS, Moliterno DJ, Steg PG, Teirstein P, Werf FVD, Wallentin L. Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: An expert consensus American Heart Journal. 144: 615-624. PMID 12360156 DOI: 10.1067/Mhj.2002.124405 |
0.389 |
|
| 2002 |
Cohen M, Fasseas P, Singh VP, McBride R, Orford JL, Kussmaul WG. Impact of intra-aortic balloon counterpulsation with different balloon volumes on cardiac performance in humans. Catheterization and Cardiovascular Interventions. 57: 199-204. PMID 12357520 DOI: 10.1002/Ccd.10304 |
0.308 |
|
| 2002 |
Lewis BE, Matthai WH, Cohen M, Moses JW, Hursting MJ, Leya F. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia Catheterization and Cardiovascular Interventions. 57: 177-184. PMID 12357516 DOI: 10.1002/Ccd.10276 |
0.414 |
|
| 2002 |
Cohen M, Théroux P, Borzak S, Frey MJ, White HD, Van Mieghem W, Senatore F, Lis J, Mukherjee R, Harris K, Bigonzi F. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin. American Heart Journal. 144: 470-7. PMID 12228784 DOI: 10.1067/Mhj.2002.126115 |
0.413 |
|
| 2002 |
Fox KAA, Antman EM, Cohen M, Bigonzi F. Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention. American Journal of Cardiology. 90: 477-482. PMID 12208405 DOI: 10.1016/S0002-9149(02)02517-1 |
0.434 |
|
| 2002 |
Cohen M. Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update. Drugs. 62: 1755-1770. PMID 12149045 DOI: 10.2165/00003495-200262120-00005 |
0.362 |
|
| 2002 |
Cohen M, Ferguson JJ, Freedman RJ, Miller MF, Reddy RC, Ohman EM, Stone GW, Christenson J, Joseph DL. Comparison of outcomes after 8 vs. 9.5 French size intra-aortic balloon counterpulsation catheters based on 9,332 patients in the prospective Benchmark registry. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 56: 200-6. PMID 12112913 DOI: 10.1002/Ccd.10188 |
0.354 |
|
| 2002 |
Sabatine MS, McCabe CH, Morrow DA, Giugliano RP, Lemos JAd, Cohen M, Antman EM, Braunwald E. Identification of patients at high risk for death and cardiac ischemic events after hospital discharge. American Heart Journal. 143: 966-970. PMID 12075250 DOI: 10.1067/Mhj.2002.122870 |
0.354 |
|
| 2002 |
Arjomand H, Surabhi SK, Cohen M. Unfractionated versus fractionated heparin for percutaneous coronary intervention. Current Cardiology Reports. 4: 327-333. PMID 12052272 DOI: 10.1007/S11886-002-0069-6 |
0.385 |
|
| 2002 |
Stone GW, Moliterno DJ, Bertrand M, Neumann FJ, Herrmann HC, Powers ER, Grines CL, Moses JW, Cohen DJ, Cohen EA, Cohen M, Wolski K, DiBattiste PM, Topol EJ. Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial. Circulation. 105: 2347-54. PMID 12021219 DOI: 10.1161/01.Cir.0000017635.82128.8C |
0.351 |
|
| 2002 |
Cohen M, Antman EM. Superiority of Enoxaparin Over Unfractionated Heparin for the Treatment of Acute Coronary Syndromes Pharmacotherapy. 22: 542-550. PMID 11939692 DOI: 10.1592/Phco.22.7.542.33668 |
0.332 |
|
| 2002 |
Cohen M, Antman EM, Murphy SA, Radley D. Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes. American Heart Journal. 143: 63-9. PMID 11773913 DOI: 10.1067/Mhj.2002.119767 |
0.369 |
|
| 2002 |
Cohen M, Antman EM. Enoxaparin and Unfractionated Heparin in Acute Coronary Syndromes Without ST-segment Elevation Thrombosis and Haemostasis. 88: 884-886. DOI: 10.1055/S-0037-1613326 |
0.34 |
|
| 2002 |
Stone GW, Moliterno DJ, Bertrand M, Neumann F, Herrmann HC, Powers ER, Grines CL, Cohen DJ, Cohen EA, Cohen M, Piedmonte M, DiBattiste PM. Abstracts - ACCIS2002 (angiography & interventional cardiology)Impact of clinical syndrome acuity on the differential response to two glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET trial Journal of the American College of Cardiology. 39. DOI: 10.1016/S0735-1097(02)80091-2 |
0.36 |
|
| 2001 |
Cohen M, Antman EM, Gurfinkel EP, Radley D. Enoxaparin in unstable angina/non-ST-segment elevation myocardial infarction: treatment benefits in prespecified subgroups. Journal of Thrombosis and Thrombolysis. 12: 199-206. PMID 11981102 DOI: 10.1023/A:1015259706522 |
0.407 |
|
| 2001 |
Berkowitz SD, Stinnett S, Cohen M, Fromell GJ, Bigonzi F. Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non–ST-segment elevation acute myocardial infarction American Journal of Cardiology. 88: 1230-1234. PMID 11728348 DOI: 10.1016/S0002-9149(01)02082-3 |
0.406 |
|
| 2001 |
Cohen M. The role of low-molecular-weight heparin in the management of acute coronary syndromes. Current Opinion in Cardiology. 16: 384-389. PMID 11704710 DOI: 10.1097/00001573-200111000-00012 |
0.407 |
|
| 2001 |
Ferguson JJ, Cohen M, Freedman RJ, Stone GW, Miller MF, Joseph DL, Ohman EM. The current practice of intra-aortic balloon counterpulsation: Results from the benchmark registry Journal of the American College of Cardiology. 38: 1456-1462. PMID 11691523 DOI: 10.1016/S0735-1097(01)01553-4 |
0.384 |
|
| 2001 |
Cohen M. Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes: Gusto IV-ACS. The Lancet. 357: 1899-1900. PMID 11425405 DOI: 10.1016/S0140-6736(00)05088-1 |
0.312 |
|
| 2001 |
Cohen M. The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction. Journal of Thrombosis and Thrombolysis. 11: 171-174. PMID 11406733 DOI: 10.1023/A:1011284902244 |
0.313 |
|
| 2000 |
Cohen M. Calming the plaque to delay intervention for 24 hours in acute coronary syndromes. American Journal of Cardiology. 86: 18-26. PMID 11206014 DOI: 10.1016/S0002-9149(00)01477-6 |
0.405 |
|
| 2000 |
Cohen M, Maritz F, Gensini GF, Danchin N, Timerman A, Huber K, Gurfinkel EP, White H, Fox KAA, Vittori L, Le-Louer V, Bigonzi F. The TETAMI trial: The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in the treatment of acute myocardial infarction for patients not thrombolyzed: Methods and design Journal of Thrombosis and Thrombolysis. 10: 241-246. PMID 11122544 DOI: 10.1023/A:1026543107533 |
0.399 |
|
| 2000 |
Goodman SG, Barr A, Sobtchouk A, Cohen M, Fromell GJ, Laperrière L, Hill C, Langer A. Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy. Journal of the American College of Cardiology. 36: 1507-1513. PMID 11079650 DOI: 10.1016/S0735-1097(00)00915-3 |
0.351 |
|
| 2000 |
Cohen M. The role of low-molecular-weight heparins in arterial diseases: Optimizing antithrombotic therapy Thrombosis Research. 100. PMID 11053626 DOI: 10.1016/S0049-3848(00)00273-5 |
0.424 |
|
| 2000 |
Cohen M, Turpie A. Management of unstable angina and myocardial infarction. The Lancet. 356: 1193. PMID 11030322 DOI: 10.1016/S0140-6736(05)72890-7 |
0.313 |
|
| 2000 |
Cohen M. Update on the Management of Acute Coronary Syndromes The Cardiology. 93: 210-219. PMID 11025346 DOI: 10.1159/000007029 |
0.395 |
|
| 2000 |
Cohen M, Antman EM, Gurfinkel E, Turpie AG, Furst J, Bigonzi F, Radley D. Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction. The American Journal of Cardiology. 86: 553-6, A9. PMID 11009278 DOI: 10.1016/S0002-9149(00)01014-6 |
0.357 |
|
| 2000 |
Goodman SG, Cohen M, Bigonzi F, Gurfinkel EP, Radley DR, Le Iouer V, Fromell GJ, Demers C, Turpie AG, Califf RM, Fox KA, Langer A. Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events. Journal of the American College of Cardiology. 36: 693-8. PMID 10987586 DOI: 10.1016/S0735-1097(00)00808-1 |
0.348 |
|
| 2000 |
Sohsten Rv, Kopistansky C, Cohen M, Kussmaul WG. Cardiac tamponade in the "new device" era: evaluation of 6999 consecutive percutaneous coronary interventions. American Heart Journal. 140: 279-283. PMID 10925343 DOI: 10.1067/Mhj.2000.107996 |
0.402 |
|
| 2000 |
Cohen M, Stinnett SS, Weatherley BD, Gurfinkel EP, Fromell GJ, Goodman SG, Fox KAA, Califf RM. Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy American Heart Journal. 139: 962-970. PMID 10827375 DOI: 10.1067/Mhj.2000.106915 |
0.379 |
|
| 2000 |
Balen RM, Marra CA, Zed PJ, Cohen M, Frighetto L. Cost-effectiveness analysis of enoxaparin versus unfractionated heparin for acute coronary syndromes. A Canadian hospital perspective. Pharmacoeconomics. 16: 533-42. PMID 10662478 DOI: 10.2165/00019053-199916050-00009 |
0.346 |
|
| 1999 |
Cohen M, Théroux P, Weber S, Laramée P, Huynh T, Borzak S, Diodati JG, Squire IB, Deckelbaum LI, Thornton AR, Harris KE, Sax FL, Lo MW, White HD. Combination therapy with tirofiban and enoxaparin in acute coronary syndromes. International Journal of Cardiology. 71: 273-81. PMID 10636535 DOI: 10.1016/S0167-5273(99)00171-0 |
0.338 |
|
| 1999 |
Antman EM, Cohen M. Newer antithrombin agents in acute coronary syndromes American Heart Journal. 138. PMID 10577463 DOI: 10.1053/Hj.1999.V138.A102297 |
0.378 |
|
| 1999 |
Antman EM, Cohen M, Radley D, McCabe C, Rush J, Premmereur J, Braunwald E. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. Circulation. 100: 1602-8. PMID 10517730 DOI: 10.1161/01.Cir.100.15.1602 |
0.323 |
|
| 1999 |
Gurfinkel E, Duronto E, Colorio C, Bozovich G, Cohen M, Mautner B. Thrombotic Reactant Markers in Non-ST Segment Elevation Acute Coronary Syndromes Treated with Either Enoxaparin (Low Molecular Weight Heparin) or Unfractionated Heparin Journal of Thrombosis and Thrombolysis. 8: 227-232. PMID 10500313 DOI: 10.1023/A:1008922527826 |
0.355 |
|
| 1998 |
Galatro KM, Adams PC, Cohen M, McBride R, Blanke H. Bleeding Complications and INR Control of Combined Warfarin and Low-Dose Aspirin Therapy in Patients with Unstable Angina and Non-Q-Wave Myocardial Infarction. Journal of Thrombosis and Thrombolysis. 5: 249-255. PMID 10767121 DOI: 10.1023/A:1008800110830 |
0.41 |
|
| 1998 |
Cohen M. New therapies for unstable angina and non-Q-wave myocardial infarction: Recent clinical trials American Heart Journal. 135. PMID 9628448 DOI: 10.1053/Hj.1998.V135.90302 |
0.401 |
|
| 1998 |
Mark DB, Cowper PA, Berkowitz SD, Davidson-Ray L, DeLong ER, Turpie AG, Califf RM, Weatherley B, Cohen M. Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction]. Circulation. 97: 1702-7. PMID 9591764 DOI: 10.1161/01.Cir.97.17.1702 |
0.382 |
|
| 1997 |
Cohen M, Adams PC, McBride R, Blanke H, Fuster V. Prospective Comparison of Patient Characteristics and Outcome of Non-prior Aspirin Users versus Aspirin Users with Unstable Angina or Non-Q-Wave Myocardial Infarction Treated with Combination Antithrombotic Therapy Journal of Thrombosis and Thrombolysis. 4: 275-280. PMID 10639270 DOI: 10.1023/A:1008855220129 |
0.362 |
|
| 1997 |
Cohen M, Blaber R, Demers C, Gurfinkel EP, Langer A, Fromell G, Turpie AGG, Premmereur J. The ESSENCE trial: Efficacy and safety of subcutaneous enoxaparin in unstable angina and non-Q-wave MI: A double-blind, randomized, parallel-group, multicenter study comparing enoxaparin and intravenous unfractionated heparin: Methods and design Journal of Thrombosis and Thrombolysis. 4: 271-274. DOI: 10.1023/A:1008803203290 |
0.396 |
|
| 1996 |
Kereiakes J, Kleiman NS, Ambrose J, Cohen M, Rodriguez S, Palabrica T, Herrmann HC, Sutton JM, Weaver WD, McKee DB, Fitzpatrick V, Sax FL. Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty. Journal of the American College of Cardiology. 27: 536-542. PMID 8606262 DOI: 10.1016/0735-1097(95)00500-5 |
0.39 |
|
| 1995 |
Patel JJ, Kopisyansky C, Boston B, Kuretu MLR, McBride R, Cohen M. Prospective evaluation of complications associated with percutaneous intraaortic balloon counterpulsation The American Journal of Cardiology. 76: 1205-1207. PMID 7484915 DOI: 10.1016/S0002-9149(99)80341-5 |
0.316 |
|
| 1995 |
Cohen M. Monitoring anticoagulation during percutaneous coronary interventions Journal of Thrombosis and Thrombolysis. 1: 285-288. DOI: 10.1007/Bf01060738 |
0.333 |
|
| 1994 |
Cohen M, Adams PC, Parry G, Xiong J, Chamberlain D, Wieczorek I, Fox KA, Chesebro JH, Strain J, Keller C. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Circulation. 89: 81-88. PMID 8281698 DOI: 10.1161/01.Cir.89.1.81 |
0.375 |
|
| 1994 |
Topol EJ, Fuster V, Harrington RA, Califf RM, Kleiman NS, Kereiakes DJ, Cohen M, Chapekis A, Gold HK, Tannenbaum MA. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial. Circulation. 89: 1557-66. PMID 8149521 DOI: 10.1161/01.Cir.89.4.1557 |
0.376 |
|
| 1993 |
Lansman SL, Cohen M, Galla JD, Machac J, Quintana CS, Ergin MA, Griepp RB. Coronary bypass with ejection fraction of 0.20 or less using centigrade cardioplegia: long-term follow-up. The Annals of Thoracic Surgery. 56: 480-5; discussion 48. PMID 8379719 DOI: 10.1016/0003-4975(93)90883-J |
0.356 |
|
| 1993 |
Charney R, Cohen M. The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size. American Heart Journal. 126: 937-45. PMID 8213453 DOI: 10.1016/0002-8703(93)90710-Q |
0.383 |
|
| 1993 |
Cohen M, Xiong J, Parry G, Adams PC, Chamberlain D, Wieczorek I, Fox KAA, McBrede R, Chesebro JH, Fuster V. Prospective comparision of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy Journal of the American College of Cardiology. 22: 1338-1343. PMID 7901254 DOI: 10.1016/0735-1097(93)90540-H |
0.365 |
|
| 1992 |
Betriu A, Heras M, Cohen M, Fuster V. Unstable angina: Outcome according to clinical presentation Journal of the American College of Cardiology. 19: 1659-1663. PMID 1593063 DOI: 10.1016/0735-1097(92)90633-X |
0.406 |
|
| 1991 |
Badimon L, Badimon JJ, Cohen M, Chesebro JH, Fuster V. Vessel wall-related risk factors in acute vascular events. Drugs. 42: 1-9. PMID 1726211 DOI: 10.2165/00003495-199100425-00003 |
0.321 |
|
| 1990 |
Kern MJ, Cohen M, Talley JD, Litvack F, Serota H, Aguirre F, Deligonul U, Bashore TM. Early ambulation after 5 French diagnostic cardiac catheterization: Results of a multicenter trial☆ Journal of the American College of Cardiology. 15: 1475-1483. PMID 2188985 DOI: 10.1016/0735-1097(90)92813-H |
0.373 |
|
| 1990 |
Cohen M, Fuster V. Insights into the pathogenetic mechanisms of unstable angina. Haemostasis. 20: 102-112. PMID 2083862 DOI: 10.1159/000216167 |
0.417 |
|
| 1990 |
Cohen M, Hawkins L, Greenberg S, Fuster V. Quantitative analysis of the admission electrocardiogram predicts extent of coronary disease and outcome in rest angina Journal of the American College of Cardiology. 15. DOI: 10.1016/0735-1097(90)92395-I |
0.308 |
|
| 1989 |
Cohen M, Fuster V, Steele PM, Driscoll D, McGoon DC. Coarctation of the aorta: Long-term follow-up and prediction of outcome after surgical correction Circulation. 80: 840-845. PMID 2791247 DOI: 10.1161/01.Cir.80.4.840 |
0.331 |
|
| 1989 |
Rentrop KP, Feit F, Sherman W, Stecy P, Hosat S, Cohen M, Rey M, Ambrose J, Nachamie M, Schwartz W, Cole W, Perdoncin R, Thornton JC. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial. Journal of the American College of Cardiology. 14: 58-64. PMID 2500472 DOI: 10.1016/0735-1097(89)90054-5 |
0.411 |
|
| 1988 |
Stein B, Israel DH, Cohen M, Fuster V. Pathogenesis of Coronary Occlusion Hospital Practice. 23: 87-99. PMID 3128570 DOI: 10.1080/21548331.1988.11703454 |
0.369 |
|
| 1988 |
Cohen M, Charney R, Hershman R, Fuster V, Gorlin R. Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. Journal of the American College of Cardiology. 12: 1193-8. PMID 2971701 DOI: 10.1016/0735-1097(88)92599-5 |
0.37 |
|
| 1987 |
Ambrose JA, Hjemdahl-Monsen C, Borrico S, Sherman W, Cohen M, Gorlin R, Fuster V. Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction. Journal of the American College of Cardiology. 9: 1156-65. PMID 3553276 DOI: 10.1016/S0735-1097(87)80321-2 |
0.366 |
|
| 1987 |
Cohen M, Scharpf SJ, Rentrop KP. Prospective analysis of electrocardiographic variables as markers for extent and location of acute wall motion abnormalities observed during coronary angioplasty in human subjects Journal of the American College of Cardiology. 10: 17-24. PMID 2955016 DOI: 10.1016/S0735-1097(87)80154-7 |
0.37 |
|
| 1986 |
Farhi J, Cohen M, Fuster V. The broad spectrum of unstable angina pectoris and its implications for future controlled trials American Journal of Cardiology. 58: 547-550. PMID 3751918 DOI: 10.1016/0002-9149(86)90031-7 |
0.405 |
|
| 1985 |
Blanke H, Cohen M, Karsch KR, Fagerstrom R, Rentrop KP. Prevalence and significance of residual flow to the infarct zone during the acute phase of myocardial infarction Journal of the American College of Cardiology. 5: 827-831. PMID 3973287 DOI: 10.1016/S0735-1097(85)80419-8 |
0.34 |
|
| 1985 |
Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects Journal of the American College of Cardiology. 5: 587-592. PMID 3156171 DOI: 10.1016/S0735-1097(85)80380-6 |
0.359 |
|
| 1984 |
Rentrop KP, Cohen M, Hosat ST. Thrombolytic therapy in acute myocardial infarction: Review of clinical trials American Journal of Cardiology. 54: 29. PMID 6439024 DOI: 10.1016/S0002-9149(84)80310-0 |
0.413 |
|
| Show low-probability matches. |